Silexion Therapeutics Corp - Ordinary Shares (SLXN) SEC filings
SLXN SEC filings moved a median of -1.07% by the close. SLXN SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the SLXN overview →
66 measured SLXN SEC filing events.
Where these SLXN SEC filings landedvs 64 measured SLXN SEC filing reactions
| Middle 50% of SLXN SEC filing reactions | -3.85% to +3.34% |
|---|---|
| Median reaction (to close) | -1.07% |
| Measured reactions | 64 |
Point-in-time · zero look-ahead
Half of the 64 SLXN SEC filing events with a measured close landed between -3.85% and +3.34%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form DEFA14A Silexion Therapeutics | SEC filing · Form DEFA14A | +2.81% | +0.52% | |
| Form DEF 14A Silexion Therapeutics For: Oct 05 | SEC filing · Form DEF | -3.80% | -2.16% | |
| Form 8-K Silexion Therapeutics For: Sep 30 | SEC filing · Form 8-K | -3.09% | +3.28% | |
| Form 8-K Silexion Therapeutics For: Sep 28 | SEC filing · Form 8-K | -0.16% | +1.69% | |
| Form 8-K Silexion Therapeutics For: Sep 28 | SEC filing · Form 8-K | -1.03% | -5.26% | |
| Form 8-K Silexion Therapeutics For: Sep 25 | SEC filing · Form 8-K | -1.03% | -5.26% | |
| Form PRE 14A Silexion Therapeutics For: Sep 25 | SEC filing · Form PRE | -1.03% | -5.26% | |
| Form DEFA14A Silexion Therapeutics | SEC filing · Form DEFA14A | +0.03% | +3.83% | |
| Form DEFA14A Silexion Therapeutics | SEC filing · Form DEFA14A | -1.37% | +1.76% | |
| Form DEF 14A Silexion Therapeutics For: Aug 24 | SEC filing · Form DEF | +0.44% | +1.36% | |
| Form 8-K Silexion Therapeutics For: Aug 21 | SEC filing · Form 8-K | -1.75% | -2.49% | |
| Form 10-Q Silexion Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -0.43% | +0.29% | |
| Form 8-K Silexion Therapeutics For: Aug 14 | SEC filing · Form 8-K | -0.43% | +0.29% | |
| Form PRE 14A Silexion Therapeutics For: Aug 14 | SEC filing · Form PRE | -1.84% | +2.18% | |
| Form 8-K Silexion Therapeutics For: Aug 13 | SEC filing · Form 8-K | -0.43% | +0.29% | |
| Form EFFECT Silexion Therapeutics | SEC filing · Form EFFECT | +5.31% | +3.51% | |
| Form 8-K Silexion Therapeutics For: Aug 10 | SEC filing · Form 8-K | — | — | |
| Form S-1/A Silexion Therapeutics | SEC filing · Form S-1 | -10.74% | -30.54% | |
| Form S-1 Silexion Therapeutics | SEC filing · Form S-1 | -3.31% | — | |
| Form 8-K Silexion Therapeutics For: Aug 04 | SEC filing · Form 8-K | -3.33% | -7.69% | |
| Form 8-K Silexion Therapeutics For: Aug 03 | SEC filing · Form 8-K | -1.57% | +2.09% | |
| Form 8-K Silexion Therapeutics For: Jul 31 | SEC filing · Form 8-K | -1.57% | +2.09% | |
| Form 8-K Silexion Therapeutics For: Jul 29 | SEC filing · Form 8-K | -0.63% | +15.00% | |
| Form 8-K Silexion Therapeutics For: Jul 21 | SEC filing · Form 8-K | +0.39% | -1.56% | |
| Form DEFA14A Silexion Therapeutics | SEC filing · Form DEFA14A | +0.00% | -3.10% | |
| Form EFFECT Silexion Therapeutics | SEC filing · Form EFFECT | -1.27% | -1.64% | |
| Form DEF 14A Silexion Therapeutics For: Jun 16 | SEC filing · Form DEF | -4.49% | +8.61% | |
| Form S-3 Silexion Therapeutics | SEC filing · Form S-3 | -3.43% | -14.33% | |
| Form PRE 14A Silexion Therapeutics For: Jun 03 | SEC filing · Form PRE | -2.94% | +4.20% | |
| Form 8-K Silexion Therapeutics For: May 29 | SEC filing · Form 8-K | +1.86% | +18.87% | |
| Form S-8 Silexion Therapeutics | SEC filing · Form S-8 | +1.86% | +18.87% | |
| Form 8-K Silexion Therapeutics For: May 26 | SEC filing · Form 8-K | -1.74% | +2.21% | |
| Form 10-K/A Silexion Therapeutics For: Dec 31 | SEC filing · Form 10-K | -4.21% | -12.57% | |
| Form 8-K Silexion Therapeutics For: May 18 | SEC filing · Form 8-K | -1.44% | -3.77% | |
| Form 10-Q Silexion Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -1.44% | -3.77% | |
| Form 8-K Silexion Therapeutics For: May 15 | SEC filing · Form 8-K | -1.44% | -3.77% | |
| Form 8-K Silexion Therapeutics For: May 14 | SEC filing · Form 8-K | -10.62% | -0.34% | |
| Form 8-K Silexion Therapeutics For: May 13 | SEC filing · Form 8-K | -0.56% | -8.18% | |
| Form EFFECT Silexion Therapeutics | SEC filing · Form EFFECT | -3.80% | +15.80% | |
| Form POS AM Silexion Therapeutics | SEC filing · Form POS | +1.85% | -2.78% | |
| Form 8-K Silexion Therapeutics For: May 05 | SEC filing · Form 8-K | -5.22% | -8.11% | |
| Form 8-K Silexion Therapeutics For: Apr 28 | SEC filing · Form 8-K | -5.17% | -17.27% | |
| Form DEFA14A Silexion Therapeutics | SEC filing · Form DEFA14A | -12.68% | +0.16% | |
| Form DEF 14A Silexion Therapeutics For: Apr 09 | SEC filing · Form DEF | +3.61% | -5.41% | |
| Form PRE 14A Silexion Therapeutics For: Mar 30 | SEC filing · Form PRE | — | +7.56% | |
| Form 8-K Silexion Therapeutics For: Mar 25 | SEC filing · Form 8-K | -1.41% | -7.75% | |
| Form 8-K Silexion Therapeutics For: Mar 24 | SEC filing · Form 8-K | -9.52% | +6.35% | |
| Form 8-K Silexion Therapeutics For: Mar 23 | SEC filing · Form 8-K | -9.52% | +6.35% | |
| Form 10-K Silexion Therapeutics For: Dec 31 | SEC filing · Form 10-K | — | -3.17% | |
| Form DEFA14A Silexion Therapeutics | SEC filing · Form DEFA14A | -0.63% | -2.50% | |
| Form DEF 14A Silexion Therapeutics For: Feb 23 | SEC filing · Form DEF | +2.08% | +4.17% | |
| Form S-8 Silexion Therapeutics | SEC filing · Form S-8 | +1.27% | -0.64% | |
| Form PRE 14A Silexion Therapeutics For: Feb 13 | SEC filing · Form PRE | +0.00% | -0.63% | |
| Form 8-K Silexion Therapeutics For: Feb 03 | SEC filing · Form 8-K | — | -3.28% | |
| Form 8-K Silexion Therapeutics For: Jan 06 | SEC filing · Form 8-K | -3.82% | -4.09% | |
| Form 8-K Silexion Therapeutics For: Dec 16 | SEC filing · Form 8-K | -4.15% | -1.51% | |
| Form 8-K Silexion Therapeutics For: Dec 02 | SEC filing · Form 8-K | -6.60% | -11.46% | |
| Form 8-K Silexion Therapeutics For: Nov 25 | SEC filing · Form 8-K | +7.04% | +12.68% | |
| Form 10-Q Silexion Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +1.07% | +4.30% | |
| Form 8-K Silexion Therapeutics For: Nov 12 | SEC filing · Form 8-K | +1.07% | +4.30% | |
| Form S-3 Silexion Therapeutics | SEC filing · Form S-3 | -0.90% | -5.37% | |
| Form EFFECT Silexion Therapeutics | SEC filing · Form EFFECT | +0.00% | +11.47% | |
| Form 8-K Silexion Therapeutics For: Sep 30 | SEC filing · Form 8-K | -7.34% | -7.61% | |
| Form 8-K Silexion Therapeutics For: Sep 26 | SEC filing · Form 8-K | +0.00% | -3.14% | |
| Form S-3 Silexion Therapeutics | SEC filing · Form S-3 | +0.00% | -3.14% | |
| Form 8-K Silexion Therapeutics For: Sep 25 | SEC filing · Form 8-K | -0.52% | -2.08% |
Keep exploring
More SLXN: earnings → · analyst actions → · SLXN overview →